Cited by 225Mosquito-borne diseases and controlEndoplasmic Reticulum Stress and DiseaseViral Infectious Diseases and Gene Expression in Insects

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Antiviral Effects of an Iminosugar Derivative on Flavivirus Infections

Open access

Wu, Shu-Fen, Lee, Chyan-Jang, Liao, Ching-Len, Dwek, Raymond A., Zitzmann, Nicole, Lin, Yi-Ling·2002·Journal of Virology

DOI 10.1128/jvi.76.8.3596-3604.2002PMC PMC136089

Open this paper in CoChat — free account

Abstract

Endoplasmic reticulum (ER) alpha-glucosidase inhibitors, which block the trimming step of N-linked glycosylation, have been shown to eliminate the production of several ER-budding viruses. Here we investigated the effects of one such inhibitor, N-nonyl-deoxynojirimycin (NN-DNJ), a 9-carbon alkyl iminosugar derivative, on infection by Japanese encephalitis virus (JEV) and dengue virus serotype 2 (DEN-2). In the presence of NN-DNJ, JEV and DEN-2 infections were suppressed in a dose-dependent manner. This inhibitory effect appeared to influence DEN-2 infection more than JEV infection, since lower concentrations of NN-DNJ substantially blocked DEN-2 replication. Secretion of the flaviviral glycoproteins E and NS1 was greatly reduced, and levels of DEN-2 viral RNA replication measured by fluorogenic reverse transcription-PCR were also decreased, by NN-DNJ. Notably, the viral glycoproteins, prM, E, and NS1 were found to associate transiently with the ER chaperone calnexin, and this interaction was affected by NN-DNJ, suggesting a potential role of calnexin in the folding of flaviviral glycoproteins. Additionally, in a mouse model of lethal challenge by JEV infection, oral delivery of NN-DNJ reduced the mortality rate. These findings show that NN-DNJ has an antiviral effect on flavivirus infection, likely through interference with virus replication at the posttranslational modification level, occurring mainly in the ER.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/jvi.76.8.3596-3604.2002

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Dengue and Dengue Hemorrhagic Fever
Gubler, D. J. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.480 · Cited by 4,394
Intracellular Functions of N-Linked Glycans
Helenius, A., & Aebi, A. M. (2001) · Science · doi:10.1126/science.291.5512.2364 · Cited by 2,405
FLAVIVIRUS GENOME ORGANIZATION, EXPRESSION, AND REPLICATION
Chambers, T. J., Hahn, C. S., Galler, R., & Rice, C. M. (1990) · Annual Review of Microbiology · doi:10.1146/annurev.mi.44.100190.003245 · Cited by 2,018
Origin of the West Nile Virus Responsible for an Outbreak of Encephalitis in the Northeastern United States
Lanciotti, R. S., Roehrig, J. T., Deubel, V., Smith, J., Parker, M., Steele, K., Crise, B., Volpe, K. E., Crabtree, M. B., Scherret, J. H., et al. (1999) · Science · doi:10.1126/science.286.5448.2333 · Cited by 1,593
Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control.
Hammond, C., Braakman, I., & Helenius, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.913 · Cited by 841
Dengue: the risk to developed and developing countries.
Monath, T. P. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2395 · Cited by 787
Protein Glucosylation and Its Role in Protein Folding
Parodi, A. J. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.69 · Cited by 659
Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase
Gruters, R. A., Neefjes, J., Tersmette, M., de Goede, R. E. Y., Tulp, A., Huisman, H. G., Miedema, F. F., & Ploegh, H. L. (1987) · Nature · doi:10.1038/330074a0 · Cited by 578
Association of folding intermediates of glycoproteins with calnexin during protein maturation
Ou, W., Cameron, P. H., Thomas, D. Y., & Bergeron, J. J. M. (1993) · Nature · doi:10.1038/364771a0 · Cited by 559
SSR alpha and associated calnexin are major calcium binding proteins of the endoplasmic reticulum membrane.
Wada, I., Rindress, D., Cameron, P. H., Ou, W. J., Doherty, J. J., Louvard, D., Bell, A. W., Dignard, D., Thomas, D. Y., & Bergeron, J. J. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55036-5 · Cited by 558

Show all 49 references

Research works printed but not linked: 2

Monath, T. P., and F. X. Heinz. 1996. Flaviviruses, p. 961-1034. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
Rice, C. M. 1996. Flaviviridae: the viruses and their replication, p. 931-959. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.

Sorted by citations

Exploitation of glycosylation in enveloped virus pathobiology
Watanabe, Y., Bowden, T. A., Wilson, I. A., & Crispin, M. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.05.012 · Cited by 489
The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives
Pavlović, D., Neville, D. C. A., Argaud, O., Blumberg, B., Dwek, R. A., Fischer, W. B., & Zitzmann, N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031527100 · Cited by 390
Self-citation
Japanese Encephalitis—A Pathological and Clinical Perspective
Ghosh, D., & Basu, A. (2009) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000437 · Cited by 340
Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond
Boldescu, V., Behnam, M. A. M., Vasilakis, N., & Klein, C. D. P. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.33 · Cited by 309
Castanospermine, a Potent Inhibitor of Dengue Virus Infection In Vitro and In Vivo
Whitby, K., Pierson, T. C., Geiss, B. J., Lane, K. C., Engle, M. J., Zhou, Y., Doms, R. W., & Diamond, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.8698-8706.2005 · Cited by 297
Strategies for development of dengue virus inhibitors
Noble, C. G., Chen, Y., Dong, H., Gu, F., Lim, S. P., Schul, W., Wang, Q.-Y., & Shi, P. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.12.011 · Cited by 279
Flavivirus Infection Activates the XBP1 Pathway of the Unfolded Protein Response To Cope with Endoplasmic Reticulum Stress
Yu, C.-Y., Hsu, Y.-W., Liao, C., & Lin, Y. (2006) · Journal of Virology · doi:10.1128/jvi.00879-06 · Cited by 257
Self-citation
A Dengue Fever Viremia Model in Mice Shows Reduction in Viral Replication and Suppression of the Inflammatory Response after Treatment with Antiviral Drugs
Schul, W., Liu, W., Xu, H., Flamand, M., & Vasudevan, S. G. (2007) · The Journal of Infectious Diseases · doi:10.1086/511310 · Cited by 248
N-Linked Glycosylation of West Nile Virus Envelope Proteins Influences Particle Assembly and Infectivity
Hanna, S. L., Pierson, T. C., Sánchez, M. D., Ahmed, A. A., Murtadha, M., & Doms, R. W. (2005) · Journal of Virology · doi:10.1128/jvi.79.21.13262-13274.2005 · Cited by 230
West Nile virus: where are we now?
Granwehr, B. P., Lillibridge, K. M., Higgs, S., Mason, P. W., Aronson, J. M., Campbell, G. A., & Barrett, A. D. T. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01128-4 · Cited by 227
Essential Role of Dengue Virus Envelope Protein N Glycosylation at Asparagine-67 during Viral Propagation
Mondotte, J. A., Lozach, P., Amara, A., & Gamarnik, A. V. (2007) · Journal of Virology · doi:10.1128/jvi.00116-07 · Cited by 226
Antiviral drug discovery: broad-spectrum drugs from nature
Martínez, J. P., Sasse, F., Brönstrup, M., Díez, J., & Meyerhans, A. (2014) · Natural Product Reports · doi:10.1039/c4np00085d · Cited by 206
Flavivirus Activates Phosphatidylinositol 3-Kinase Signaling To Block Caspase-Dependent Apoptotic Cell Death at the Early Stage of Virus Infection
Lee, C.-J., Liao, C., & Lin, Y. (2005) · Journal of Virology · doi:10.1128/jvi.79.13.8388-8399.2005 · Cited by 200
Self-citation
Hepatitis C therapeutics: current status and emerging strategies
Tan, S., Pause, A., Shi, Y., & Sonenberg, N. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd937 · Cited by 197
Blocking of the Alpha Interferon-Induced Jak-Stat Signaling Pathway by Japanese Encephalitis Virus Infection
Lin, R.-J., Liao, C., Lin, E., & Lin, Y. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.9285-9294.2004 · Cited by 191
Self-citation
Mouse models of dengue virus infection and disease
Yauch, L. E., & Shresta, S. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.06.010 · Cited by 170
The Medicinal Chemistry of Dengue Virus
Behnam, M. A. M., Nitsche, C., Boldescu, V., & Klein, C. D. P. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01653 · Cited by 152
Bitter-sweet symphony: glycan–lectin interactions in virus biology
Van Breedam, W., Pöhlmann, S., Favoreel, H. W., de Groot, R. J., & Nauwynck, H. J. (2014) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12052 · Cited by 141
Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus†
Steinmann, E., Whitfield, T., Kallis, S., Dwek, R. A., Zitzmann, N., Pietschmann, T., & Bartenschlager, R. F. W. (2007) · Hepatology · doi:10.1002/hep.21686 · Cited by 141
Self-citation
Molecular strategies to inhibit the replication of RNA viruses
Leyssen, P., Clercq, E. D., & Neyts, J. H. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.01.004 · Cited by 140
c-Src protein kinase inhibitors block assembly and maturation of dengue virus
Chu, J. J. H., & Yang, P. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611681104 · Cited by 140
Recent advances in antiviral drug development towards dengue virus
Troost, B., & Smit, J. M. (2020) · Current Opinion in Virology · doi:10.1016/j.coviro.2020.07.009 · Cited by 138
The many faces of the flavivirus NS1 protein offer a multitude of options for inhibitor design
Watterson, D., Modhiran, N., & Young, P. R. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.02.014 · Cited by 128
Differential Protein Modulation in Midguts of Aedes aegypti Infected with Chikungunya and Dengue 2 Viruses
Tchankouo-Nguetcheu, S., Khun, H., Pincet, L., Roux, P., Bahut, M., Huerre, M., Guette, C., & Choumet, V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013149 · Cited by 127
Hydroxychloroquine-Inhibited Dengue Virus Is Associated with Host Defense Machinery
Wang, L.-F., Lin, Y.-S., Huang, N.-C., Yu, C.-Y., Tsai, W.-L., Chen, J.-J., Kubota, T., Matsuoka, M., Chen, S.-R., Yang, C., et al. (2015) · Journal of Interferon and Cytokine Research · doi:10.1089/jir.2014.0038 · Cited by 118
Self-citation
Progress on the development of therapeutics against West Nile virus
Diamond, M. S. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.05.006 · Cited by 120
Triaryl Pyrazoline Compound Inhibits Flavivirus RNA Replication
Puig‐Basagoiti, F., Tilgner, M., Forshey, B. M., Philpott, S. M., Espina, N. G., Wentworth, D. E., Goebel, S. J., Masters, P. S., Falgout, B., Ren, P., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1320-1329.2006 · Cited by 120
Antiviral therapies targeting host ER alpha-glucosidases: Current status and future directions
Chang, J., Block, T. M., & Guo, J. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.06.011 · Cited by 119
Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein
Kato, D., Era, S., Watanabe, I., Arihara, M., Sugiura, N., Kimata, K., Suzuki, Y., Morita, K., Hidari, K. I. P. J., & Suzuki, T. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2010.09.002 · Cited by 119
Novel Dengue Virus-Specific NS2B/NS3 Protease Inhibitor, BP2109, Discovered by a High-Throughput Screening Assay
Yang, C.-C., Hsieh, Y., Lee, S., Wu, S., Liao, C., Tsao, C., Chao, Y., Chern, J., Wu, C., & Yueh, A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00855-10 · Cited by 119
Self-citation
Mouse Models to Study Dengue Virus Immunology and Pathogenesis
Zellweger, R. L. M., & Shresta, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00151 · Cited by 116
In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses
Kampmann, T., Yennamalli, R. M., Campbell, P., Stoermer, M. J., Fairlie, D. P., Kobe, B., & Young, P. R. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.09.007 · Cited by 116
Revisiting Dengue Virus–Host Cell Interaction
Acosta, E. G., Kumar, A., & Bartenschlager, R. F. W. (2014) · Advances in virus research · doi:10.1016/b978-0-12-800098-4.00001-5 · Cited by 122
Intracellular Assembly and Secretion of Recombinant Subviral Particles from Tick-Borne Encephalitis Virus
Lorenz, I. C., Kartenbeck, J., Mezzacasa, A., Allison, S. L., Heinz, F. X., & Helenius, A. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.4370-4382.2003 · Cited by 115
Iminosugar antivirals: the therapeutic sweet spot
Alonzi, D. S., Scott, K. A., Dwek, R. A., & Zitzmann, N. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160182 · Cited by 112
Self-citation
Successful Propagation of Flavivirus Infectious cDNAs by a Novel Method To Reduce the Cryptic Bacterial Promoter Activity of Virus Genomes
Pu, S., Wu, R., Yang, C.-C., Jao, T., Tsai, M., Wang, J.-C., Lin, H.-M., Chao, Y., & Yueh, A. (2011) · Journal of Virology · doi:10.1128/jvi.01986-10 · Cited by 113
Flaviviral NS4b, chameleon and jack‐in‐the‐box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention
Żmurko, J., Neyts, J. H., & Dallmeier, K. (2015) · Reviews in Medical Virology · doi:10.1002/rmv.1835 · Cited by 109
Novel Five‐Membered Iminocyclitol Derivatives as Selective and Potent Glycosidase Inhibitors: New Structures for Antivirals and Osteoarthritis
Liang, P., Cheng, W., Lee, Y.-L., Yu, H., Wu, Y., Lin, Y., & Wong, C. (2006) · ChemBioChem · doi:10.1002/cbic.200500321 · Cited by 109
Self-citation
The Cellular Antiviral Protein Viperin Is Attenuated by Proteasome-Mediated Protein Degradation in Japanese Encephalitis Virus-Infected Cells
Chan, Y.-L., Chang, T.-H., Liao, C., & Lin, Y. (2008) · Journal of Virology · doi:10.1128/jvi.00438-08 · Cited by 105
Self-citation
Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo
Chang, J., Schul, W., Butters, T. D., Yip, A., Liu, B., Goh, A., Lakshminarayana, S. B., Alonzi, D. S., Reinkensmeier, G., Pan, X., et al. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2010.11.002 · Cited by 100
An iminosugar with potent inhibition of dengue virus infection in vivo
Perry, S. T., Buck, M. D., Plummer, E. M., Penmasta, R., Batra, H., Stavale, E. J., Warfield, K. L., Dwek, R. A., Butters, T. D., Alonzi, D. S., et al. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.01.004 · Cited by 93
Self-citation
Pharmaceutical significance of azepane based motifs for drug discovery: A critical review
Zha, G., Rakesh, K. P., Manukumar, H. M. G., Shantharam, C. S., & Long, S. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.11.031 · Cited by 97
Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses
Chang, J., Warren, T. K., Zhao, X., Gill, T., Guo, F., Wang, L., Comunale, M. A., Du, Y., Alonzi, D. S., Yu, W., et al. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.03.023 · Cited by 88
A Novel Dengue Virus Inhibitor, BP13944, Discovered by High-Throughput Screening with Dengue Virus Replicon Cells Selects for Resistance in the Viral NS2B/NS3 Protease
Yang, C.-C., Hu, H.-S., Wu, R., Wu, S., Lee, S., Jiaang, W., Chern, J., Huang, Z.-S., Wu, H., Chang, C.-M., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01281-13 · Cited by 88
Self-citation
High-Content Assay to Identify Inhibitors of Dengue Virus Infection
Shum, D., Smith, J. L., Hirsch, A. J., Bhinder, B., Radu, C., Stein, D. A., Nelson, J. A., Früh, K., & Djaballah, H. (2010) · Assay and Drug Development Technologies · doi:10.1089/adt.2010.0321 · Cited by 87
The Medicinal Chemistry of Dengue Fever
Stevens, A. J., Gahan, M. E., Mahalingam, S., & Keller, P. A. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900652e · Cited by 85
The first synthesis of substituted azepanes mimicking monosaccharides: a new class of potent glycosidase inhibitors
Li, H., Blériot, Y., Chantereau, C., Mallet, J., Sollogoub, M., Zhang, Y., Rodriguez‐García, E., Vogel, P., Jiménez‐Barbero, J., & Sînaÿ, P. (2004) · Organic & Biomolecular Chemistry · doi:10.1039/b402542c · Cited by 86
Novel Imino Sugar Derivatives Demonstrate Potent Antiviral Activity against Flaviviruses
Chang, J., Wang, L., Ma, D., Qu, X., Guo, H., Xu, X., Mason, P. M., Bourne, N., Moriarty, R. M., Gu, B., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01457-08 · Cited by 86
Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases—Not Glycolipid Processing Enzymes
Sayce, A. C., Alonzi, D. S., Killingbeck, S. S., Tyrrell, B. E., Hill, M. L., Caputo, A. T., Iwaki, R., Kinami, K., Ide, D., Kiappes, J. L., et al. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004524 · Cited by 83
Self-citation
Natural products as promising drug candidates for the treatment of hepatitis B and C
Wohlfarth, C., & Efferth, T. (2008) · Acta Pharmacologica Sinica · doi:10.1038/aps.2008.5 · Cited by 83
The endoplasmic reticulum protein folding factory and its chaperones: new targets for drug discovery?
McLaughlin, M., & Vandenbroeck, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01064.x · Cited by 84
How glycosylation affects glycosylation: the role of N-glycans in glycosyltransferase activity
Mikolajczyk, K. P., Kaczmarek, R., & Czerwiński, M. (2020) · Glycobiology · doi:10.1093/glycob/cwaa041 · Cited by 81
Replication-Competent Recombinant Vesicular Stomatitis Virus Encoding Hepatitis C Virus Envelope Proteins
Tani, H., Komoda, Y., Matsuo, E., Suzuki, K., Hamamoto, I., Yamashita, T., Moriishi, K., Fujiyama, K., Kanto, T., Hayashi, N., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00608-07 · Cited by 78
Identification of novel target sites and an inhibitor of the dengue virus E protein
Yennamalli, R. M., Subbarao, N., Kampmann, T., McGeary, R. P., Young, P. R., & Kobe, B. (2009) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-009-9263-6 · Cited by 77
The Use of Calnexin and Calreticulin by Cellular and Viral Glycoproteins
Pieren, M., Galli, C., Denzel, A., & Molinari, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501020200 · Cited by 72
Role of N-glycosylation on Zika virus E protein secretion, viral assembly and infectivity
Mossenta, M., Marchese, S., Poggianella, M., Slon-Campos, J., & Burrone, Ó. R. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.022 · Cited by 70
A Short N-Terminal Peptide Motif on Flavivirus Nonstructural Protein NS1 Modulates Cellular Targeting and Immune Recognition
Youn, S., Cho, H., Fremont, D. H., & Diamond, M. (2010) · Journal of Virology · doi:10.1128/jvi.00775-10 · Cited by 69
Inhibitors of Endoplasmic Reticulum α-Glucosidases Potently Suppress Hepatitis C Virus Virion Assembly and Release
Qu, X., Pan, X., Weidner, J. M., Yu, W., Alonzi, D. S., Xu, X., Butters, T. D., Block, T. M., Guo, J., & Chang, J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01319-10 · Cited by 68
N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery
Pollock, S., Dwek, R. A., Burton, D. R., & Zitzmann, N. (2008) · AIDS · doi:10.1097/qad.0b013e32830efd96 · Cited by 67
Self-citation
Japanese Encephalitis Virus: An Update on the Potential Antivirals and Vaccines
Srivastava, K. S., Jeswani, V., Pal, N., Bohra, B., Vishwakarma, V., Bapat, A. A., Patnaik, Y. P., Khanna, N., & Shukla, R. (2023) · Vaccines · doi:10.3390/vaccines11040742 · Cited by 66
N-methylisatin-beta-thiosemicarbazone derivative (SCH 16) is an inhibitor of Japanese encephalitis virus infection in vitro and in vivo
Sebastian, L. J., Desai, A. S., Madhusudana, S. N., Yogeeswari, P., Sriram, D., & Ravi, V. (2008) · Virology Journal · doi:10.1186/1743-422x-5-64 · Cited by 65
Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2
Christy, M. P., Uekusa, Y., Gerwick, L. G., & Gerwick, W. H. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.0c00968 · Cited by 63
Role of the N-linked glycans of the prM and E envelope proteins in tick-borne encephalitis virus particle secretion
Goto, A., Yoshii, K., Obara, M., Ueki, T., Mizutani, T., Kariwa, H., & Takashima, I. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.11.068 · Cited by 64
Inhibition of Endoplasmic Reticulum-Resident Glucosidases Impairs Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63 Spike Protein-Mediated Entry by Altering the Glycan Processing of Angiotensin I-Converting Enzyme 2
Zhao, X., Guo, F., Comunale, M. A., Mehta, A. S., Sehgal, M., Jain, P., Cuconati, A., Lin, H., Block, T. M., Chang, J., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03999-14 · Cited by 63
Dengue Virus Entry as Target for Antiviral Therapy
Alen, M. M. F., & Schols, D. (2012) · Journal of Tropical Medicine · doi:10.1155/2012/628475 · Cited by 62
Effects of Interferon, Ribavirin, and Iminosugar Derivatives on Cells Persistently Infected with Noncytopathic Bovine Viral Diarrhea Virus
Durantel, D., Carrouée‐Durantel, S., Branza‐Nichita, N., Dwek, R. A., & Zitzmann, N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.497-504.2004 · Cited by 61
Self-citation
Antiviral Profiles of Novel Iminocyclitol Compounds against Bovine Viral Diarrhea Virus, West Nile Virus, Dengue Virus and Hepatitis B Virus
Gu, B., Mason, P. W., Wang, L., Norton, P. A., Bourne, N., Moriarty, R. M., Mehta, A. S., Despande, M., Shah, R., & Block, T. M. (2007) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020701800105 · Cited by 60
Antiviral Activity of Emetine Dihydrochloride Against Dengue Virus Infection
Low, J. S. Y., Chen, K. C., Wu, K. X., Ng, M. L., & Chu, J. J. H. (2009) · Journal of Antivirals & Antiretrovirals · doi:10.4172/jaa.1000009 · Cited by 60
Design, Synthesis, and Biological Evaluation of N -Alkylated Deoxynojirimycin (DNJ) Derivatives for the Treatment of Dengue Virus Infection
Yu, W., Gill, T., Wang, L., Du, Y., Ye, H., Qu, X., Guo, J., Cuconati, A., Zhao, K., Block, T. M., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300171v · Cited by 59
Pathogenesis and Inhibition of Flaviviruses from a Carbohydrate Perspective
Kim, S. Y., Li, B., & Linhardt, R. J. (2017) · Pharmaceuticals · doi:10.3390/ph10020044 · Cited by 59
A high-throughput assay using dengue-1 virus-like particles for drug discovery
Qing, M., Liu, W., Yuan, Z., Gu, F., & Shi, P. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2010.02.313 · Cited by 58
Natural iminosugar derivatives of 1-deoxynojirimycin inhibit glycosylation of hepatitis viral envelope proteins.
Jacob, J. R., Mansfield, K. G., You, J. E., Tennant, B. C., & Kim, Y. H. (2007) · PubMed · Cited by 57
Antivirus effectiveness of ivermectin on dengue virus type 2 in Aedes albopictus
Xu, T., Han, Y., Liu, W., Pang, X.-Y., Zheng, B., Zhang, Y., & Zhou, X. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006934 · Cited by 57
Identification of Three Antiviral Inhibitors against Japanese Encephalitis Virus from Library of Pharmacologically Active Compounds 1280
Fang, J., Sun, L., Peng, G., Xu, J., Zhou, R., Cao, S., Chen, H., & Song, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078425 · Cited by 56
Roles of NS1 Protein in Flavivirus Pathogenesis
Perera, D. R., Ranadeva, N. D. K., Sirisena, K. A., & Wijesinghe, K. J. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00566 · Cited by 54
Iminosugars: Promising therapeutics for influenza infection
Tyrrell, B. E., Sayce, A. C., Warfield, K. L., Miller, J. L., & Zitzmann, N. (2016) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2016.1242868 · Cited by 54
Self-citation
Iminosugars: A host-targeted approach to combat Flaviviridae infections
DeWald, L. E., Starr, C., Butters, T. D., Treston, A. M., & Warfield, K. L. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104881 · Cited by 54
Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2
Rajasekharan, S., Bonotto, R. M., Alves, L. N., Kazungu, Y., Poggianella, M., Martínez-Orellana, P., Skoko, N., Polez, S., & Marcello, A. (2021) · Viruses · doi:10.3390/v13050808 · Cited by 54
ROCK is Involved in Vimentin Phosphorylation and Rearrangement Induced by Dengue Virus
Lei, S., Tian, Y., Xiao, W., Li, S., Rao, X., Zhang, J., Yang, J., Hu, X., & Chen, W. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9665-x · Cited by 52
Cellular Targets for the Treatment of Flavivirus Infections
Zakaria, M. K., Carletti, T., & Marcello, A. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00398 · Cited by 52
Antiviral drug research for Japanese encephalitis: an updated review
Joe, S., Salam, A. A. A., Neogi, U., Naren Babu, N., & Mudgal, P. P. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00355-2 · Cited by 53
New Synthetic Seven‐Membered 1‐Azasugars Displaying Potent Inhibition Towards Glycosidases and Glucosylceramide Transferase
Li, H., Liu, T., Zhang, Y., Favre, S., Bello, C., Vogel, P., Butters, T. D., Oikonomakos, N. G., Marrot, J., & Blériot, Y. (2008) · ChemBioChem · doi:10.1002/cbic.200700496 · Cited by 49
Targeting a host process as an antiviral approach against dengue virus
Sayce, A. C., Miller, J. L., & Zitzmann, N. (2010) · Trends in Microbiology · doi:10.1016/j.tim.2010.04.003 · Cited by 49
Self-citation
The ER Glycoprotein Quality Control System
Dejgaard, S. Y., Nicolay, J., Taheri, M., Thomas, D. Y., & Bergeron, J. J. M. (2004) · Current Issues in Molecular Biology · doi:10.21775/cimb.006.029 · Cited by 49
Involvement of cyclophilin B in the replication of Japanese encephalitis virus
Kambara, H., Tani, H., Mori, Y., Abe, T., Katoh, H., Fukuhara, T., Taguwa, S., Moriishi, K., & Matsuura, Y. (2011) · Virology · doi:10.1016/j.virol.2011.01.011 · Cited by 49
Selection of the biological activity of DNJ neoglycoconjugates through click length variation of the side chain
Guisot, N. E. S., Alonzi, D. S., Reinkensmeier, G., Butters, T. D., Norez, C., Becq, F., Shimada, Y., Nakagawa, S., Kato, A., Blériot, Y., et al. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c1ob05119a · Cited by 48
Surfactant-Modified Nanoclay Exhibits an Antiviral Activity with High Potency and Broad Spectrum
Liang, J., Wei, J.-C., Lee, Y.-L., Hsu, S., Lin, J., & Lin, Y. (2014) · Journal of Virology · doi:10.1128/jvi.03256-13 · Cited by 46
Self-citation
Mechanisms of Antiviral Activity of Iminosugars Against Dengue Virus
Miller, J. L., Tyrrell, B. E., & Zitzmann, N. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-8727-1_20 · Cited by 45
Self-citation
Screening of Natural Extracts for Inhibitors against Japanese Encephalitis Virus Infection
Guo, J., Jia, X., Liu, Y., Wang, S., Cao, J., Zhang, B., Xiao, G., & Wang, W. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02373-19 · Cited by 45
Imino Sugars That are Less Toxic but More Potent as Antivirals, In Vitro, Compared with N-n-Nonyl DNJ
Mehta, A. S., Ouzounov, S., Jordan, R., Simsek, E., Lu, X., Moriarty, R. M., Jacob, G., Dwek, R. A., & Block, T. M. (2002) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020201300505 · Cited by 44
Self-citation
Antiviral effect of dehydroepiandrosterone on Japanese encephalitis virus infection
Chang, C., Ou, Y., Raung, S., & Chen, C. (2005) · Journal of General Virology · doi:10.1099/vir.0.81123-0 · Cited by 42
Bispidine-Amino Acid Conjugates Act as a Novel Scaffold for the Design of Antivirals That Block Japanese Encephalitis Virus Replication
Haridas, V., Rajgokul, K. S., Sadanandan, S., Agrawal, T., Sharvani, V., Gopalakrishna, M. V. S., Bijesh, M. B., Kumawat, K. L., Basu, A., & Medigeshi, G. R. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002005 · Cited by 42
The endoplasmic reticulum (ER): a crucial cellular hub in flavivirus infection and potential target site for antiviral interventions
Verhaegen, M., & Vermeire, K. (2024) · npj Viruses · doi:10.1038/s44298-024-00031-7 · Cited by 39
Glycosylation of dengue virus glycoproteins and their interactions with carbohydrate receptors: possible targets for antiviral therapy
Idris, F., Muharram, S. H., & Diah, S. (2016) · Archives of Virology · doi:10.1007/s00705-016-2855-2 · Cited by 43
Contemporary Strategies and Current Trends in Designing Antiviral Drugs against Dengue Fever via Targeting Host-Based Approaches
Ahammad, F., Rashid, T. R. T. A., Mohamed, M., Tanbin, S., & Fuad, F. A. A. (2019) · Microorganisms · doi:10.3390/microorganisms7090296 · Cited by 41
Mechanistic insights into the Japanese encephalitis virus RNA dependent RNA polymerase protein inhibition by bioflavonoids from Azadirachta indica
Dwivedi, V. D., Singh, A., El-Kafrawy, S. A., Alandijany, T. A., Faizo, A. A., Bajrai, L. H., Kamal, M. A., & Azhar, E. I. (2021) · Scientific Reports · doi:10.1038/s41598-021-96917-0 · Cited by 41
Competitive inhibitor of cellular α-glucosidases protects mice from lethal dengue virus infection
Chang, J., Schul, W., Yip, A., Xu, X., Guo, J., & Block, T. M. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.08.003 · Cited by 41
Recent Advances in Flavivirus Antiviral Drug Discovery and Vaccine Development
Ray, D., & Shi, P. (2006) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489106775244055 · Cited by 41
Broad‐Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View
Felicetti, T., Manfroni, G., Cecchetti, V., & Cannalire, R. (2020) · ChemMedChem · doi:10.1002/cmdc.202000464 · Cited by 37
Yet another ten stories on antiviral drug discovery (part D): Paradigms, paradoxes, and paraductions
Clercq, E. D. (2009) · Medicinal Research Reviews · doi:10.1002/med.20173 · Cited by 37

Authors: Wu, S.-F., Lee, C.-J., Liao, C.-L., Dwek, R. A., Zitzmann, N., & Lin, Y.-L.
Affiliations: Institute of Biomedical Sciences, Academia Sinica (TW)
National Defense Medical Center (TW)
University of Oxford (GB)
Corresponding author: Lin, Yi-Ling
ORCID: Wu, Shu-Fen
Liao, Ching-Len
Dwek, Raymond A.
Zitzmann, Nicole
Lin, Yi-Ling
Venue: Journal of Virology
Publisher: American Society for Microbiology
Published: 2002-04-15
Volume: 76
Issue: 8
Pages: 3596-3604
ISSN: 0022-538X (ISSN-L)
1098-5514
DOI: 10.1128/jvi.76.8.3596-3604.2002
PMC: PMC136089
OpenAlex: W2159159412
Cited by: 220
References: 49
Citations by year: 2026: 5 · 2025: 6 · 2024: 2 · 2023: 4 · 2022: 6 · 2021: 4 · 2020: 14 · 2019: 8 · 2018: 9 · 2017: 11 · 2016: 8 · 2015: 7 · 2014: 10 · 2013: 13 · 2012: 10
FWCI: 6.97
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Journal of Virology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Mosquito-borne diseases and control
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
Keywords: iminosugars, flavivirus, Japanese encephalitis virus, dengue virus type 2, N-glycosylation, calnexin, glycoprotein folding, NS1 protein, PRM, viral RNA replication, antiviral agents, oral antiviral therapy
MeSH terms: Animals, Antiviral Agents, Cell Line, Dengue, Dengue Virus, Encephalitis Virus, Japanese, Encephalitis, Japanese, Female, Cricetinae, Mice, Inbred ICR, 1-Deoxynojirimycin, Mice, Glycoside Hydrolase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Antiviral Effects of an Iminosugar Derivative on Flavivirus Infections

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks